Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
226 ‘Off-the-shelf’ CD19-CAR-T cells generated from umbilical cord blood display superior anti-tumor fitness and lower pro-inflammatory activity as compared to peripheral blood-derived engineered T cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
